Discovery of a Highly Selective JAK2 Inhibitor, BMS-911543, for the Treatment of Myeloproliferative Neoplasms.
Wan, H., Schroeder, G.M., Hart, A.C., Inghrim, J., Grebinski, J., Tokarski, J.S., Lorenzi, M.V., You, D., Mcdevitt, T., Penhallow, B., Vuppugalla, R., Zhang, Y., Gu, X., Iyer, R., Lombardo, L.J., Trainor, G.L., Ruepp, S., Lippy, J., Blat, Y., Sack, J.S., Khan, J.A., Stefanski, K., Sleczka, B., Mathur, A., Sun, J.H., Wong, M.K., Wu, D.R., Li, P., Gupta, A., Arunachalam, P.N., Pragalathan, B., Narayanan, S., K C, N., Kuppusamy, P., Purandare, A.V.
Acs Med.Chem.Lett.